Suppr超能文献

γδ 调节性 T 细胞在人类乳腺癌中的特异性募集。

Specific recruitment of γδ regulatory T cells in human breast cancer.

机构信息

Authors' Affiliations: Division of Infectious Diseases, Allergy & Immunology, Department of Internal Medicine, Departments of Surgery, Molecular Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri; Department of Immunology and Microbiology, Shandong Medical College, Linyi; and Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China.

出版信息

Cancer Res. 2013 Oct 15;73(20):6137-48. doi: 10.1158/0008-5472.CAN-13-0348. Epub 2013 Aug 19.

Abstract

Understanding the role of different subtypes of tumor-infiltrating lymphocytes (TIL) in the immunosuppressive tumor microenvironment is essential for improving cancer treatment. Enriched γδ1 T-cell populations in TILs suppress T-cell responses and dendritic cell maturation in breast cancer, where their presence is correlated negatively with clinical outcomes. However, mechanism(s) that explain the increase in this class of regulatory T cells (γδ Treg) in patients with breast cancer have yet to be elucidated. In this study, we show that IP-10 secreted by breast cancer cells attracted γδ Tregs. Using neutralizing antibodies against chemokines secreted by breast cancer cells, we found that IP-10 was the only functional chemokine that causes γδ Tregs to migrate toward breast cancer cells. In a humanized NOD-scid IL-2Rγ(null) (NSG) mouse model, human breast cancer cells attracted γδ Tregs as revealed by a live cell imaging system. IP-10 neutralization in vivo inhibited migration and trafficking of γδ Tregs into breast tumor sites, enhancing tumor immunity mediated by tumor-specific T cells. Together, our studies show how γδ Tregs accumulate in breast tumors, providing a rationale for their immunologic targeting to relieve immunosuppression in the tumor microenvironment.

摘要

了解不同类型的肿瘤浸润淋巴细胞(TIL)在免疫抑制性肿瘤微环境中的作用对于改善癌症治疗至关重要。在乳腺癌中,TIL 中富含的 γδ1 T 细胞群抑制 T 细胞反应和树突状细胞成熟,其存在与临床结果呈负相关。然而,解释乳腺癌患者中这种调节性 T 细胞(γδ Treg)增加的机制尚未阐明。在这项研究中,我们表明乳腺癌细胞分泌的 IP-10 吸引了 γδ Tregs。使用针对乳腺癌细胞分泌的趋化因子的中和抗体,我们发现 IP-10 是唯一能够促使 γδ Tregs 向乳腺癌细胞迁移的功能性趋化因子。在人源化 NOD-scid IL-2Rγ(null)(NSG)小鼠模型中,通过活细胞成像系统显示,人乳腺癌细胞吸引了 γδ Tregs。体内的 IP-10 中和抑制了 γδ Tregs 向乳腺肿瘤部位的迁移和转移,增强了肿瘤特异性 T 细胞介导的肿瘤免疫。总之,我们的研究表明了 γδ Tregs 如何在乳腺肿瘤中积累,为针对它们以缓解肿瘤微环境中的免疫抑制提供了依据。

相似文献

1
Specific recruitment of γδ regulatory T cells in human breast cancer.γδ 调节性 T 细胞在人类乳腺癌中的特异性募集。
Cancer Res. 2013 Oct 15;73(20):6137-48. doi: 10.1158/0008-5472.CAN-13-0348. Epub 2013 Aug 19.

引用本文的文献

4
Potential of gamma/delta T cells for solid tumor immunotherapy.γ/δ T 细胞在实体瘤免疫治疗中的潜力。
Front Immunol. 2024 Aug 26;15:1466266. doi: 10.3389/fimmu.2024.1466266. eCollection 2024.
8
The capability of heterogeneous γδ T cells in cancer treatment.异质性 γδ T 细胞在癌症治疗中的作用。
Front Immunol. 2023 Nov 24;14:1285801. doi: 10.3389/fimmu.2023.1285801. eCollection 2023.

本文引用的文献

3
Human regulatory T cells induce T-lymphocyte senescence.人类调节性 T 细胞诱导 T 淋巴细胞衰老。
Blood. 2012 Sep 6;120(10):2021-31. doi: 10.1182/blood-2012-03-416040. Epub 2012 Jun 21.
7
CXCR3 ligands: redundant, collaborative and antagonistic functions.CXCR3 配体:冗余、协作和拮抗功能。
Immunol Cell Biol. 2011 Feb;89(2):207-15. doi: 10.1038/icb.2010.158. Epub 2011 Jan 11.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验